Apotea (APOTEA) — Capital Reinvestment Ratio
Latest as of June 2026:
0.04x
Apotea (APOTEA) has a Capital Reinvestment Ratio of 0.04x as of June 2026, meaning it reinvests 0% of its operating cash flow (Skr76.80 Million) in capital expenditures (Skr2.90 Million). Check Apotea (APOTEA) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
Skr76.80 Million
SEK
Capital Expenditures
Skr2.90 Million
SEK
Data as of
Jun 2026
Most recent filing
Apotea Capital Reinvestment Ratio (2021–2025)
This chart tracks Apotea's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Apotea cash conversion from operations.
Annual Capital Reinvestment Ratio for Apotea (2021–2025)
Year-by-year Capital Reinvestment Ratio for Apotea from 2021 to 2025. See Apotea free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | Skr333.30 Million | Skr215.60 Million | ▼ -18.6% |
| 2024 | 0.79x | Skr206.20 Million | Skr163.80 Million | ▲ +41.6% |
| 2023 | 0.56x | Skr215.80 Million | Skr121.10 Million | ▼ -87.6% |
| 2022 | 4.51x | Skr31.50 Million | Skr142.10 Million | ▲ +1158.5% |
| 2021 | 0.36x | Skr227.30 Million | Skr81.48 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow